IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 153 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,254,000 | -3.4% | 459,961 | +15.7% | 0.03% | -5.6% |
| Q2 2017 | $7,506,000 | +135.4% | 397,539 | +112.7% | 0.04% | +125.0% |
| Q1 2017 | $3,189,000 | -69.8% | 186,924 | -78.7% | 0.02% | -66.7% |
| Q2 2015 | $10,564,000 | -54.2% | 875,976 | -39.2% | 0.05% | -53.8% |
| Q1 2015 | $23,052,000 | -20.0% | 1,440,722 | -23.4% | 0.10% | -25.2% |
| Q4 2014 | $28,822,000 | +36.9% | 1,881,312 | +15.7% | 0.14% | +36.3% |
| Q3 2014 | $21,058,000 | +21.4% | 1,625,438 | +43.6% | 0.10% | +20.0% |
| Q2 2014 | $17,352,000 | +23.3% | 1,131,884 | -0.9% | 0.08% | +21.4% |
| Q1 2014 | $14,071,000 | – | 1,142,091 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |